Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2761 AL 2775

Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis

Pluta R, Ułamek-Kozioł M.

Adv Exp Med Biol. 2019;1118:71-82. doi: 10.1007/978-3-030-05542-4_4.

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred

Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, Sperling RA, Reiman EM, Lopera F, Quiroz YT.

J Prev Alzheimers Dis. 2019;6(2):112-120. doi: 10.14283/jpad.2019.6.

M/EEG-Based Bio-Markers to Predict the MCI and Alzheimer's Disease: A Review From the ML Perspective

Yang S, Bornot JMS, Wong-Lin K, Prasad G.

IEEE Trans Biomed Eng. 2019 Oct;66(10):2924-2935. doi: 10.1109/TBME.2019.2898871. Epub 2019 Feb 12.

Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis

Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB.

Cell Mol Life Sci. 2019 May;76(10):1833-1863. doi: 10.1007/s00018-019-03040-5. Epub 2019 Feb 15.

European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol

Solomon A, Kivipelto M, Molinuevo JL, Tom B, Ritchie CW; EPAD Consortium.

BMJ Open. 2019 Feb 19;8(12):e021017. doi: 10.1136/bmjopen-2017-021017.

Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative

Sato K, Mano T, Ihara R, Suzuki K, Tomita N, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H, Iwatsubo T, Toda T, Iwata A; Alzheimer’s Disease Neuroimaging Initiative, and Japanese Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019;68(2):777-788. doi: 10.3233/JAD-181115.

The Alzheimer Precision Medicine Initiative

Hampel H, Vergallo A, Perry G, Lista S; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2019;68(1):1-24. doi: 10.3233/JAD-181121.

Rationale and Design of a Clinical Trial of Adapted Tango to Improve Negative Health Impacts in Middle Aged African-American Female Caregivers of Persons with Alzheimer's Disease (ACT Trial)

Hackney ME, McCullough LE, Bay AA, Silverstein HA, Hart AR, Shin RJ, Wharton W.

J Alzheimers Dis. 2019;68(2):767-775. doi: 10.3233/JAD-181130.

Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study

Scaricamazza E, Colonna I, Sancesario GM, Assogna F, Orfei MD, Franchini F, Sancesario G, Mercuri NB, Liguori C.

Neurol Sci. 2019 Jul;40(7):1377-1382. doi: 10.1007/s10072-019-03840-4. Epub 2019 Mar 22.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease

Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, Raymont V, Leroi I, Lengyel I, Murray M, Thomas DL, Gallacher J, Lovestone S.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

[Biomarkers of Alzheimer's disease in older and oldest old patients]

Lilamand M, Cognat E, Goutagny S, Hourregue C, Hugon J, Dumurgier J, Paquet C.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Mar 1;17(1):65-72. doi: 10.1684/pnv.2019.0779.

Search for biomarkers of Alzheimer's disease: Recent insights, current challenges and future prospects

Hrubešová K, Fousková M, Habartová L, Fišar Z, Jirák R, Raboch J, Setnička V.

Clin Biochem. 2019 Oct;72:39-51. doi: 10.1016/j.clinbiochem.2019.04.002. Epub 2019 Apr 4.

Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease

Mustapic M, Tran J, Craft S, Kapogiannis D.

J Alzheimers Dis. 2019;69(2):489-498. doi: 10.3233/JAD-180578.

Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers

Farotti L, Sepe FN, Toja A, Rinaldi R, Parnetti L.

Clin Biochem. 2019 Oct;72:24-29. doi: 10.1016/j.clinbiochem.2019.04.011. Epub 2019 Apr 15.

Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease

Jiang L, Dong H, Cao H, Ji X, Luan S, Liu J.

Med Sci Monit. 2019 May 6;25:3329-3335. doi: 10.12659/MSM.914027.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias